Literature DB >> 12097605

Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4.

Elena Ryzhova1, J Charles Whitbeck, Gabriela Canziani, Susan V Westmoreland, Gary H Cohen, Roselyn J Eisenberg, Andrew Lackner, Francisco González-Scarano.   

Abstract

Aspartate 368 on human immunodeficiency virus type 1 (HIV-1) gp120 forms multiple contacts with CD4; in mutagenesis studies, its replacement by asparagine and corresponding changes in simian immunodeficiency virus SIVmac (D385N) reduced binding with CD4. Nevertheless, simian immunodeficiency virus envelopes with D385N were prevalent in several studies. Extending these observations, we also found D385N to be dominant among env clones from two rhesus macaques that progressed rapidly to simian AIDS. These envelopes showed a CD4-independent phenotype as well as reduced affinity to CD4. Moreover, an adjacent change, G383R, which was frequently coselected with D385N, further decreased binding. An optical biosensor study demonstrated that the SIVmac239 gp120 bound to CD4 with kinetics similar to those of HIV-1. However, the gp120s with D385N and G383R showed a 40-fold reduction in affinity, with a drastic increase in dissociation rate, indicating an inherently unstable complex. This finding showed that rapid progression to simian AIDS may be accompanied by the selection of CD4-independent gp120 variants with impaired CD4 binding ability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097605      PMCID: PMC136356          DOI: 10.1128/jvi.76.15.7903-7909.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.

Authors:  P D Kwong; R Wyatt; S Majeed; J Robinson; R W Sweet; J Sodroski; W A Hendrickson
Journal:  Structure       Date:  2000-12-15       Impact factor: 5.006

2.  Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.

Authors:  A L Edinger; M Ahuja; T Sung; K C Baxter; B Haggarty; R W Doms; J A Hoxie
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants.

Authors:  P Kolchinsky; E Kiprilov; J Sodroski
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops.

Authors:  P Kolchinsky; E Kiprilov; P Bartley; R Rubinstein; J Sodroski
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages.

Authors:  K Mori; M Rosenzweig; R C Desrosiers
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses.

Authors:  H Y Liu; Y Soda; N Shimizu; Y Haraguchi; A Jinno; Y Takeuchi; H Hoshino
Journal:  Virology       Date:  2000-12-05       Impact factor: 3.616

7.  The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.

Authors:  N Bannert; D Schenten; S Craig; J Sodroski
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication.

Authors:  P Kolchinsky; T Mirzabekov; M Farzan; E Kiprilov; M Cayabyab; L J Mooney; H Choe; J Sodroski
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.

Authors:  T G Edwards; T L Hoffman; F Baribaud; S Wyss; C C LaBranche; J Romano; J Adkinson; M Sharron; J A Hoxie; R W Doms
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

10.  The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain.

Authors:  J C Whitbeck; M I Muggeridge; A H Rux; W Hou; C Krummenacher; H Lou; A van Geelen; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

View more
  16 in total

1.  Simian immunodeficiency virus envelope compartmentalizes in brain regions independent of neuropathology.

Authors:  Maria F Chen; Susan Westmoreland; Elena V Ryzhova; Julio Martín-García; Samantha S Soldan; Andrew Lackner; Francisco González-Scarano
Journal:  J Neurovirol       Date:  2006-04       Impact factor: 2.643

2.  Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.

Authors:  Takeo Kuwata; Houman Dehghani; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Tatsuhiko Igarashi; Joseph Mattapallil; Mario Roederer; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.

Authors:  Po-Jen Yen; Megan E Mefford; James A Hoxie; Kenneth C Williams; Ronald C Desrosiers; Dana Gabuzda
Journal:  Virology       Date:  2014-05-08       Impact factor: 3.616

4.  CD4+ T cells support production of simian immunodeficiency virus Env antibodies that enforce CD4-dependent entry and shape tropism in vivo.

Authors:  Nicholas Francella; Sarah E Gwyn; Yanjie Yi; Bing Li; Peng Xiao; Sarah T C Elliott; Alexandra M Ortiz; James A Hoxie; Mirko Paiardini; Guido Silvestri; Cynthia A Derdeyn; Ronald G Collman
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

5.  Intrathecal humoral responses are inversely associated with the frequency of simian immunodeficiency virus macrophage-tropic variants in the central nervous system.

Authors:  Elena Ryzhova; Pyone Aye; Tom Harvey; Wei Cao; Andrew Lackner; Francisco González-Scarano
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

6.  Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques.

Authors:  Vanessa M Hirsch; Sampa Santra; Simoy Goldstein; Ronald Plishka; Alicia Buckler-White; Aruna Seth; Ilnour Ourmanov; Charles R Brown; Ronald Engle; David Montefiori; Jennifer Glowczwskie; Kevin Kunstman; Steven Wolinsky; Norman L Letvin
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.

Authors:  Takeo Kuwata; Russell Byrum; Sonya Whitted; Robert Goeken; Alicia Buckler-White; Ronald Plishka; Ranjini Iyengar; Vanessa M Hirsch
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

8.  Unique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5.

Authors:  Houman Dehghani; Bridget A Puffer; Robert W Doms; Vanessa M Hirsch
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

9.  Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.

Authors:  Adrienne E Swanstrom; Beth Haggarty; Andrea P O Jordan; Josephine Romano; George J Leslie; Pyone P Aye; Preston A Marx; Andrew A Lackner; Gregory Q Del Prete; James E Robinson; Michael R Betts; David C Montefiori; Celia C LaBranche; James A Hoxie
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

10.  Spatiotemporal dynamics of simian immunodeficiency virus brain infection in CD8+ lymphocyte-depleted rhesus macaques with neuroAIDS.

Authors:  Samantha L Strickland; Brittany D Rife; Susanna L Lamers; David J Nolan; Nazle M C Veras; Mattia C F Prosperi; Tricia H Burdo; Patrick Autissier; Brian Nowlin; Maureen M Goodenow; Marc A Suchard; Kenneth C Williams; Marco Salemi
Journal:  J Gen Virol       Date:  2014-09-09       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.